The Litmus Papers

The Litmus Papers explore quality of life in health and medicine. This is a conversation about how lifestyle, diet, activity and environment affect patient outcomes. The answers we need to develop breakthrough therapies are all around us.

That’s a Wrap: The Future of Clinical Trials

Thank you again to everyone who joined last week’s live discussion about Clinical Trials of the Future with Drs. Sam Volchenboum and Sam Blackman. We were flattered that so many of you were in attendance. We’ve already been asked to make this into a…

Litmus Health

May 23

Join us for a Live Conversation: Clinical Trials of the Future

We invite you to join us on June 6th for a live conversation on Clinical Trials of the Future. The content is valuable for anyone interested in learning how new technologies are transforming how we conduct clinical…

Litmus Health

Apr 13

Litmus is Now Free to Academic Researchers

We are delighted to announce Litmus Free. Our platform is now available to researchers in academia at zero cost.

Researchers can apply for Litmus Free here.

At a time when NIH’s budget is in…

Litmus Health

Mar 24

Litmus Health at Google Cloud Next

Our co-founder and Chief Medical Officer Dr. Sam Volchenboum recently co-presented at Google Cloud Next with University of Chicago’s Dr. Michael Howell on sensitive data management for collaborative research clouds. The are two critical components of improving the pace…

Litmus Health

Jan 31

Litmus Health is a 2017 SXSW Accelerator Finalist

Litmus Health has been accepted as a finalist for the SXSW Accelerator, hosted as part of the larger SXSW event in Austin, Texas.

Each year, the event draws tens of thousands of people from all over the world…

Litmus Health

Jan 4

Quality of Life is a Business Consideration for Clinical Trials

Today, the way in which clinical trials are run makes it hard to determine a drug’s impact on a patient’s quality of life. The primary endpoint for most drugs remains survival, meaning that the medication might help you…

Litmus Health

Nov 28, 2016

Litmus at AMIA Ignite

Last week, Dr. Samuel Volchenboum spoke at AMIA in Chicago on the topic of health-related quality of life as the ultimate endpoint. From the viewpoint of a 32 year-old woman with Crohn’s Disease, it’s easy to see that quality of life should not be a second-hand consideration for drug…

Litmus Health

Nov 16, 2016

Litmus at UChicago Innovation Fest

Our co-founder and Chief Science Officer Dr. Sam Volchenboum recently spoke at the UChicago Innovation Fest at MATTER about how Litmus is working to increase the efficiency of clinical trials.

Litmus Health

Oct 27, 2016

Litmus Health Opens Doors for Business

Our doors are officially open for business. The Litmus platform is built and deployed. We’ve put together an exceptionally strong team.

We made our way through the IRB approval process, HIPAA and 21 CFR part 11. Our first customer, the…

Litmus Health

Oct 24, 2016

Case In-Progress: Using Patient Data to Reinvent the study of IBD

In March 2016, Takeda Pharmaceuticals, University of Chicago Medicine, and the Icahn School of Medicine at Mount Sinai partnered to reinvent the way we think about the study of IBD and IBD treatment.